StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories fDA MAUDE MDR Reports — Death (Abbott)

U.S. FDA openFDA MAUDE Database

QuarterlyAnnualMonthly
Latest, Q3 2026
265
Period ended Sep 30, 2026
Change on a year earlier
+16.7%
227 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFDA MAUDE MDR Reports — Death (Abbott)Year on yearSource
Q3 2026Sep 30, 2026265+16.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2026Jun 30, 2026354+144.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2026Mar 31, 2026259+105.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2025Dec 31, 2025244+50.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2025Sep 30, 2025227+83.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2025Jun 30, 2025145-2.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2025Mar 31, 2025126-10.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2024Dec 31, 2024162+0.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2024Sep 30, 2024124-13.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2024Jun 30, 2024148+27.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2024Mar 31, 2024141+4.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2023Dec 31, 2023161+41.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2023Sep 30, 2023144+37.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2023Jun 30, 2023116+63.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2023Mar 31, 2023135+125.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2022Dec 31, 2022114+119.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Cite this data

StockData. (2026). Abbott Laboratories FDA MAUDE MDR Reports — Death (Abbott), quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-maude-death

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.